Evidence map›Paper›PMID 40435307›Full record

ArticlePloS one2025

Inaccurate labelling practices in probiotic products: A regulatory shortfall in Accra, Ghana.

Mansa Fredua-Agyeman, Emmanuel Aduamah Larbi

Abstract read
In one paragraph

Article in PloS one, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Review
  2. Review
  3. Review
  4. Review
  5. Article
  6. Review
  7. Review
  8. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Mansa Fredua-AgyemanDepartment of Pharmaceutics and Microbiology, School of Pharmacy, College of Health Sciences, University of Ghana, Legon, Accra, Ghana.ORCID https://orcid.org/0000-0001-9050-0452
Emmanuel Aduamah LarbiDepartment of Pharmaceutics and Microbiology, School of Pharmacy, College of Health Sciences, University of Ghana, Legon, Accra, Ghana.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The global market for probiotics has witnessed significant growth in recent years, driven by increased interest in their health benefits. However, amidst the substantial expansion of this industry, there are still challenges regarding their quality control, especially in the aspect of labelling accuracy, hence reliability. This study evaluated the labelling accuracy and availability of probiotic products in Ayawaso West Municipality, Accra, Ghana. Using a stratified sampling design, 120 pharmacies within the Municipality were randomly selected and assessed for availability of probiotics and labels scrutinized. Visual inspection of the product labels was carried out utilizing a probiotic product label assessment checklist developed as a guide. The checklist covered information including brand details, probiotic species/strains, cell quantity, ingredients, label claims, dosage instructions and expiration dates. The checklist was based on recommended labelling requirements by the Joint Food and Agriculture Organization of the United Nations and World Health Organization (FAO/WHO) and the Council for Responsible Nutrition (CRN) and International Probiotics Association (IPA). The findings from this study revealed 78.3% of pharmacies in the Ayawaso West Municipality offered probiotic supplements and/or probiotic foods. Disparities in recommended label requirements and the labels of probiotic products found within the Municipality was observed. Labelling issues were more prevalent in probiotic foods than supplements. Compliance for the probiotic supplements was 74% and 44% for the probiotic food. Common issues included lack of essential information like cell quantity or CFU (colony-forming-unit), lack of statement of specific probiotic strain contained in the product, lack of scientific references supporting health claims and un-existing bacteria names. The probiotic foods occasionally stated the genus, and some did not indicate species or strain contained in the product. The study sheds light on the gaps in labelling practices in the probiotic market in Ghana and advocates for greater compliance and proper regulation of probiotics.

Indexed as

Food LabelingProbioticsDietary SupplementsGhanaHumansPharmaciesQuality Control

Identifiers

PMID40435307
PMCPMC12118974

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.